Reviewed clinical summary · Source-linked · Educational use only

Is Driving Pressure-Guided Ventilation Better for Obese Patients in Bariatric Surgery?

Hormone Insight visual abstract summarising driving pressure-guided ventilation in bariatric surgery.
Visual abstract for driving pressure-guided ventilation in bariatric surgery.

Clinical Bottom Line

An RCT finds driving pressure-guided ventilation improves oxygenation and cuts intraoperative hypoxia in bariatric surgery, on physiological endpoints. PICO summary and commentary.

Summary: In morbidly obese patients undergoing laparoscopic bariatric surgery, individualising PEEP to the lowest driving pressure improved oxygenation and lung mechanics and sharply reduced intraoperative hypoxia (6.7% vs 33.3%) versus fixed PEEP, though the outcomes were physiological and short-term rather than major complications.

PICO Summary

ElementDetail
Population60 adults with BMI 40–50 undergoing elective laparoscopic bariatric surgery (30 per arm).
InterventionDriving pressure-guided ventilation: PEEP individually titrated to the lowest driving pressure after a recruitment manoeuvre.
ComparisonConventional lung-protective ventilation with fixed PEEP 5 cmH₂O after the same recruitment manoeuvre.
OutcomeHigher PaO₂/FiO₂ before extubation and postoperatively (P<0.001), better compliance, lower plateau and driving pressures. Intraoperative hypoxia 6.7% vs 33.3%; postoperative hypoxia 0% vs 23.3%. No major adverse effects.
RCT BMC Anesthesiol · 2025

Driving pressure-guided ventilation in bariatric surgery

RCT · morbid obesity · laparoscopic bariatric surgery

Trial design
BMI 40-50 bariatric surgery Enrolled & assessed RANDOMISED 1:1 Driving pressure PEEP titrated to lowest DP n = 30 Fixed PEEP Fixed PEEP 5 cmH2O n = 30 Intraoperative hypoxia
Proportion reaching endpoint
RR 0.20 intraoperative hypoxia (%) 6.7% Driving pressure 33.3% Fixed PEEP ARRARR 26.6 pts
Intraop hypoxia
6.7% vs 33.3%
driving pressure vs fixed
Postop hypoxia
0% vs 23.3%
driving pressure vs fixed
PaO2/FiO2
Higher
P<0.001
Compliance
Higher
lower plateau & DP
⬡ Bottom Line

Titrating PEEP to the lowest driving pressure improved oxygenation and lung mechanics and cut intraoperative hypoxia from 33.3% to 6.7%. Endpoints were physiological and short-term, not major complications.

Expert Commentary

This sits a little outside my own clinic, but it matters to anyone sending patients with obesity to theatre, and the rationale is sound: a single fixed PEEP cannot suit every patient’s mechanics, and driving pressure is a well-validated marker of the strain placed on aerated lung. Titrating PEEP to minimise it after recruitment is mechanically sensible, and the oxygenation and compliance gains here, with intraoperative hypoxia cut from a third of patients to under one in fourteen, are clinically meaningful in a population that desaturates easily. My reservation is the one this literature keeps running into: improved physiology does not reliably become fewer hard outcomes. The endpoints are oxygenation, compliance, and hypoxic episodes, not pulmonary complications or length of stay, the trial is single-centre with 60 patients, and larger high-versus-low PEEP trials have given mixed results on what patients actually care about. Can I use this with my patients? Not directly as an endocrinologist, but I would happily support anaesthetic colleagues adopting it as a refinement of lung-protective ventilation, since it needs only routine ventilator data. I would await a multicentre trial powered for postoperative complications before calling it definitive.

References

Elbehairy MS, Eid GM, Elzeftawy AE, Elsheikh NA, Messbah WE. Driving pressure guided ventilation versus conventional lung protective strategy in morbid obese patients undergoing laparoscopic bariatric surgery: a prospective randomized controlled study. BMC Anesthesiol. 2025;25(1):577. doi:10.1186/s12871-025-03431-1

Educational use: Hormone Insight is intended for healthcare professionals and learners. Interpret each summary alongside the primary source, local guidance, and patient-specific clinical judgement.

Subscribe now

Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.

© 2024-2026 Hormone Insight. All rights reserved.